Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

299
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Porogen-Mediated Barrier Control in Multilayered Drug-Eluting Antibacterial Films: Comparative Evaluation of PEG, PVP, and PEOx.

Pharmaceutics·2026
Same author

Magnetoelectric biodegradable uniform composite microactuators for biomedical applications.

Journal of materials chemistry. B·2026
Same author

Retraction: Triple-responsive inorganic-organic hybrid microcapsules as a biocompatible smart platform for the delivery of small molecules.

Journal of materials chemistry. B·2026
Same author

Minimally Invasive Endovascular Administration for Targeted PLGA Nanoparticles Delivery to Brain, Salivary Glands, Kidney and Lower Limbs.

Pharmaceutics·2026
Same author

Light-directed reprogramming of tumor-associated macrophages via STING agonist delivery.

Biomaterials advances·2025
Same author

The olfactory epithelium as a gateway for bloodborne nanoparticles to the central nervous system.

Biomaterials science·2025

Related Experiment Video

Updated: May 24, 2025

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

6.3K

Injectable biodegradable microchamber array films for long-term delivery of glucocorticoids.

Jiaxin Zhang1, Jordan E Read2, Gayatri Mittal3

  • 1Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|March 1, 2025
PubMed
Summary
This summary is machine-generated.

This study developed novel biodegradable polymer microchamber array films (MCAs) for sustained glucocorticoid (GC) delivery. These films offer tunable release kinetics, avoiding burst release for prolonged anti-inflammatory effects at disease sites.

Keywords:
BiodegradableCrystalGlucocorticoidMicrochamber Array filmPLAPLGAPolymer

More Related Videos

Generation of Alginate Microspheres for Biomedical Applications
10:33

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

20.7K
Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
12:22

Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering

Published on: October 26, 2016

11.8K

Related Experiment Videos

Last Updated: May 24, 2025

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

6.3K
Generation of Alginate Microspheres for Biomedical Applications
10:33

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

20.7K
Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
12:22

Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering

Published on: October 26, 2016

11.8K

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Drug Delivery Systems

Background:

  • Glucocorticoids (GCs) are potent anti-inflammatory and analgesic agents, but systemic delivery causes side effects.
  • Local delivery of GCs to disease sites (eyes, lungs, joints) minimizes systemic exposure.
  • Current local GC formulations often suffer from burst release, limiting therapeutic duration.

Purpose of the Study:

  • To develop and characterize novel biodegradable polymer microchamber array films (MCAs) for sustained glucocorticoid release.
  • To investigate the influence of polymer choice on GC release kinetics and film degradation.
  • To assess the potential for injectable and rollable MCA formulations for localized drug delivery.

Main Methods:

  • Soft lithography was employed to fabricate polymer microchamber array films (MCAs) containing glucocorticoid crystals.
  • Varying polymer compositions (PLGA 50/50, PLA) were used to modulate release rates.
  • Glucocorticoid release profiles, film degradation (size, appearance, lactic acid liberation), and zero-order release kinetics were monitored over time.

Main Results:

  • The choice of polymer significantly affected GC release duration, with PLGA 50/50 showing release over 9 weeks and PLA over a year.
  • No evidence of burst release was observed; films exhibited significant zero-order release kinetics.
  • Film degradation correlated with GC release, evidenced by changes in physical properties and lactic acid production.
  • Flexible MCAs could be rolled into fibers or injected via syringe with minimal impact on release kinetics.

Conclusions:

  • Biodegradable polymer MCAs provide a promising platform for tunable, sustained local glucocorticoid delivery.
  • The developed MCA technology minimizes burst release and achieves prolonged therapeutic effects.
  • These flexible, injectable formulations represent an innovative approach for managing localized inflammatory diseases.